ELISA and WB analyses revealed that NAT10 knockdown significantly reduced TGF‐β1 and TGF‐β2 protein levels (Figure 4E,F), suggesting that NAT10 modulates HCC progression via TGF‐β signaling. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.